1. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis
   Farida Ahangari et al, 2022, American Journal of Respiratory and Critical Care Medicine CrossRef
2. Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
   Girieca Lorusso et al, 2020, Frontiers in Oncology CrossRef
3. Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma
   Chiung-Chi Cheng et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
4. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification
   Rong-Quan He et al, 2018, International Journal of Molecular Medicine CrossRef
5. Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities
   Mohamed E. Shaker et al, 2023, International Immunopharmacology CrossRef
6. Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway
   Hye-Young Seo et al, 2021, International Journal of Molecular Sciences CrossRef